Premavathy Levasseur

480 total citations
7 papers, 436 citations indexed

About

Premavathy Levasseur is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, Premavathy Levasseur has authored 7 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Medicine, 3 papers in Molecular Biology and 3 papers in Pharmacology. Recurrent topics in Premavathy Levasseur's work include Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). Premavathy Levasseur is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers) and Pharmaceutical and Antibiotic Environmental Impacts (3 papers). Premavathy Levasseur collaborates with scholars based in Belgium, France and United States. Premavathy Levasseur's co-authors include Christine Miossec, Anne-Marie Girard, Therese‐Marie Stachyra, M. BLACK, Ken Coleman, Kenneth Coleman, Michael T. Black, John Pace, Herman Goossens and Monica Borgonovi and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.

In The Last Decade

Premavathy Levasseur

7 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Premavathy Levasseur Belgium 7 401 323 169 97 54 7 436
Maria Katsiari Greece 9 348 0.9× 208 0.6× 162 1.0× 88 0.9× 73 1.4× 20 404
Christopher Cortes United States 6 407 1.0× 283 0.9× 121 0.7× 146 1.5× 58 1.1× 7 437
Ken Coleman United States 9 331 0.8× 245 0.8× 151 0.9× 91 0.9× 35 0.6× 12 456
Tiffany Palmer United States 4 406 1.0× 266 0.8× 139 0.8× 78 0.8× 71 1.3× 8 459
Henrietta Abodakpi United States 10 497 1.2× 353 1.1× 160 0.9× 193 2.0× 78 1.4× 12 563
Tsukasa Ito-Horiyama Japan 4 450 1.1× 362 1.1× 115 0.7× 146 1.5× 66 1.2× 6 518
Angela Wardman United Kingdom 5 398 1.0× 296 0.9× 181 1.1× 170 1.8× 48 0.9× 6 455
Scott A. Becka United States 11 331 0.8× 157 0.5× 141 0.8× 70 0.7× 60 1.1× 20 412
Kenji Yamawaki Japan 8 337 0.8× 243 0.8× 82 0.5× 83 0.9× 35 0.6× 12 487

Countries citing papers authored by Premavathy Levasseur

Since Specialization
Citations

This map shows the geographic impact of Premavathy Levasseur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Premavathy Levasseur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Premavathy Levasseur more than expected).

Fields of papers citing papers by Premavathy Levasseur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Premavathy Levasseur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Premavathy Levasseur. The network helps show where Premavathy Levasseur may publish in the future.

Co-authorship network of co-authors of Premavathy Levasseur

This figure shows the co-authorship network connecting the top 25 collaborators of Premavathy Levasseur. A scholar is included among the top collaborators of Premavathy Levasseur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Premavathy Levasseur. Premavathy Levasseur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Levasseur, Premavathy, Anne-Marie Girard, Christine Miossec, John Pace, & Ken Coleman. (2015). In Vitro Antibacterial Activity of the Ceftazidime-Avibactam Combination against Enterobacteriaceae, Including Strains with Well-Characterized β-Lactamases. Antimicrobial Agents and Chemotherapy. 59(4). 1931–1934. 50 indexed citations
2.
Coleman, Ken, Premavathy Levasseur, Anne-Marie Girard, et al.. (2014). Activities of Ceftazidime and Avibactam against β-Lactamase-Producing Enterobacteriaceae in a Hollow-Fiber Pharmacodynamic Model. Antimicrobial Agents and Chemotherapy. 58(6). 3366–3372. 79 indexed citations
3.
Levasseur, Premavathy, et al.. (2014). Efficacy of a Ceftazidime-Avibactam Combination in a Murine Model of Septicemia Caused by Enterobacteriaceae Species Producing AmpC or Extended-Spectrum β-Lactamases. Antimicrobial Agents and Chemotherapy. 58(11). 6490–6495. 29 indexed citations
4.
Miossec, Christine, et al.. (2013). The β-lactamase inhibitor avibactam (NXL104) does not induce ampC β -lactamase in Enterobacter cloacae. Infection and Drug Resistance. 6. 235–235. 19 indexed citations
5.
Levasseur, Premavathy, Anne-Marie Girard, Herman Goossens, et al.. (2012). In Vitro Antibacterial Activity of the Ceftazidime-Avibactam (NXL104) Combination against Pseudomonas aeruginosa Clinical Isolates. Antimicrobial Agents and Chemotherapy. 56(3). 1606–1608. 96 indexed citations
6.
Stachyra, Therese‐Marie, et al.. (2009). In vitro activity of the  -lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. Journal of Antimicrobial Chemotherapy. 64(2). 326–329. 151 indexed citations
7.
Cateau, Estelle, Premavathy Levasseur, Monica Borgonovi, & Christine Imbert. (2006). The effect of aminocandin (HMR 3270) on the in-vitro adherence of Candida albicans to polystyrene surfaces coated with extracellular matrix proteins or fibronectin. Clinical Microbiology and Infection. 13(3). 311–315. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026